Physician profile
Daniel O Johnsrud
NPI 1427437599
$24,703.02
in general payments reported to CMS, 2019-2025
20 companies · $585 in 2025
The $585 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $123 · 2021: $1,325 · 2022: $20K · 2023: $2,115 · 2024: $110 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,609 · Travel and Lodging: $1,200 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,609.49 |
| Travel and Lodging | $1,199.84 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,880.99 | 2021-2025 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $2,760.73 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $1,240.55 | 2020-2023 | Synergy |
| Abbott Laboratories | $683.07 | 2021-2025 | Mitraclip |
| Asahi Intecc USA, INC. | $323.06 | 2021-2022 | |
| Abiomed | $299.93 | 2022 | |
| Philips North America LLC | $250.75 | 2021-2022 | |
| Medtronic Vascular, INC. | $167.41 | 2019 | |
| Cvrx, INC. | $147.66 | 2025 | Barostim Neo System |
| Endologix LLC | $142.96 | 2021 | |
| W. L. Gore & Associates, INC. | $138.47 | 2022 | |
| Shockwave Medical, INC | $131.14 | 2021 | |
| Cardiovascular Systems INC. | $120.20 | 2022 | |
| Cook Medical LLC | $108.50 | 2021 | |
| Astellas Pharma US INC | $79.99 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $73.66 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $67.50 | 2019 | |
| Akcea Therapeutics, INC. | $59.45 | 2019 | |
| Amgen INC. | $27.00 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Johnsrud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.